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Abstract
Background:  Social phobia (social anxiety disorder - SAD) is a rather common but often
undetected and undertreated psychiatric condition in youths. Screening of SAD in young individuals
in community samples is thus important in preventing negative outcomes. The present study is the
first report on the psychometric properties of the Social Phobia Screening Questionnaire for
Children and adolescents (SPSQ-C).
Methods: The SPSQ-C was administered to a community sample of high-school students. Test-
retest reliability over three weeks was evaluated (n = 127) and internal consistency was calculated
for items measuring level of fear in eight social situations. To measure concurrent validity, subjects
who reported SAD on at least one occasion and randomly selected non-cases were blindly
interviewed with the Structured Clinical Interview for DSM-IV Axis-I disorders (SCID-I), as gold
standard (n = 51).
Results: A moderate test-retest reliability, r = .60 (P < .01), and a satisfactory alpha coefficient of
.78 was found. Values of sensitivity and specificity were 71% and 86% respectively, and area under
the curve (AUC) was .79. Positive likelihood ratio (LR+) showed that a positive screening result
was five times more likely to be correct than to reflect a non-case. Negative likelihood ratio (LR -
) was .34. In addition, positive predictive value was 45% and negative predictive value was 95%. The
prevalence of self-reported SAD was found to be 7.2% at the first assessment.
Conclusion: The SPSQ-C is a short and psychometrically sound questionnaire for screening of
SAD in adolescents, with the advantage of being based on the DSM-IV criteria.
Background
Social anxiety disorder, also called social phobia, is a
rather common anxiety disorder in adolescents, though
prevalence rates are varying due to methodological and
cultural reasons as well as due to what age groups are stud-
ied [1-4]. For many young sufferers, it is a disabling con-
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dition associated with a significantly increased risk for
negative outcomes like dropping out from school [5],
depression and suicide [6,7], alcohol use disorder [8] and
cannabis dependence [9].
Even though effective psychosocial and pharmacological
treatments for childhood SAD exist [10-13] help-seeking
is low [4,14,15]. Children are usually referred to mental
health service via parents but SAD is rarely recognized by
parents and teachers [16] and mental health referral and
treatment utilization is lower in anxiety disorders than in
externalizing disorders in children and adolescents
[17,18]. If help is sought, identification of symptoms
needs to take place before treatment can be offered. While
SAD is common in primary care populations, it is often
not detected by primary care providers [19]. The use of a
reliable and valid, brief screening instrument in primary
care paediatric settings can facilitate the detection of SAD
in adolescents [20]. According to the Practice parameters
for anxiety disorders in children and adolescents [21],
routine screening for anxiety symptoms is recommended
during the initial mental health assessment due to the
high prevalence of anxiety disorders. Also, given the high
rates of comorbidity among anxiety disorders, there is a
need to correctly identify the primary diagnosis, and rule
out phenomenologically similar conditions that may be
of importance for treatment selection [22]. The Practice
parameters recommend that screening questions are
based on DSM-IV criteria [23] and use developmentally
appropriate language.
There are a few psychometrically evaluated self-report
instruments for use in the assessment of SAD in children
and adolescents. The most widely used and well estab-
lished instruments are the Social Anxiety Scale for Chil-
dren - Revised (SASC-R) [24], the Social Anxiety Scale for
Adolescents (SAS-A) [25] and the Social Phobia and Anx-
iety Inventory for Children (SPAI-C) [26]. The SPAI-C has
also been evaluated in a shorter 16-item version [27]. In
addition, the Screen for Child Anxiety Related Emotional
Disorders (SCARED) [28] can be used for the assessment
of social anxiety disorder in children. The Social Phobia
Inventory (SPIN) [29-31] has a more categorical format
and has primarily been used with adolescents. The SPIN
and the SPAI-C have been developed from instruments
that have been used in adults, as well as an established
Swedish screening instrument for use in adults, the Social
Phobia Screening Questionnaire (SPSQ) [32]. The SPSQ
has shown excellent psychometric properties, showing a
sensitivity of 100% and specificity of 95%, and has been
used in several epidemiological and treatment studies on
adults [32-37]. The SPAI-C mentioned above, has been
translated and evaluated in a Norwegian sample [38], but
to date there is no validated instrument for screening of
social anxiety in Swedish children and adolescents. In
backdrop of the need of a brief, DSM-based screening
questionnaire for use with Swedish children and adoles-
cents, a modified version for children and adolescents, the
Social Phobia Screening Questionnaire for children and
adolescents (SPSQ-C), has been developed and used in
epidemiological and descriptive studies of children rang-
ing in age from twelve to eighteen years [1,39].
While the SPSQ-C is a time-efficient and potentially use-
ful instrument based on DSM-IV criteria, it has yet to be
psychometrically evaluated. Thus, the objective of the
present study was to report preliminary results of the psy-
chometric properties of the SPSQ-C in a community sam-
ple of high-school students. Reliability was investigated
by test-retest analysis over a three-week period and by cal-
culating internal consistency for the first eight items of the
SPSQ-C, covering level of fear in different social situa-
tions. Concurrent validity, i.e. sensitivity and specificity of
the questionnaire, was evaluated using the Structured
Clinical Interview for the DSM-IV Axis I-disorders (SCID-
I) [40] as gold standard.
Methods
Procedure
Data were collected on three occasions. On the first two,
the SPSQ-C was used for the purpose of evaluating relia-
bility and on the third occasion a clinical interview was
used for establishing concurrent validity.
Two weeks before the investigation took place written
information about the study were mailed to students and
their parents. The students were also informed about vol-
untary participation at all three assessments. Data-collec-
tion for the reliability evaluation was done at the classes'
weekly class-council. Students signed written consent,
completed the screening questionnaire and answered
additional questions regarding socio-demographics. The
same procedure, with the same classes of students, was
used three weeks later. As a compensation for their partic-
ipation, the students had a chance of winning a ticket to a
movie in a lottery that was conducted in each class after all
students had completed their questionnaires at the first
and second assessment.
A case-control design was adopted for the evaluation of
validity. The procedure of a case-control study starts with
the selection of known cases and then an appropriate
number of controls are selected [41]. One week after the
last assessment, adolescents meeting the criteria for social
phobia according to the SPSQ-C, were selected if they had
reported SAD on at least one occasion except if reporting
SAD at the first assessment but not the second. Non-cases
were randomly selected for the control group.Child and Adolescent Psychiatry and Mental Health 2009, 3:36 http://www.capmh.com/content/3/1/36
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The clinical interview was conducted by telephone by two
interviewers who were blind to the participants' diagnos-
tic status on the SPSQ-C. A telephone format was chosen
due to that many of the students were living in geograph-
ically distant areas, leading to transportation difficulties.
Telephone administration of structured clinical interviews
has been found to yield reliable, valid and time-effective
data in the assessment of anxiety disorders in children
[42]. Subjects were compensated for their participation in
the interview, by movie-tickets. The study was approved
by the local ethics committee.
Subjects
Total sample
Subjects were recruited from a compulsory high school, in
a small municipality (12 000 inhabitants) in the south
middle of Sweden. The students were following the high
school Social Science Programme or the Child Recreation
Programme. These two programmes were chosen in order
to have students from a theoretically oriented and a prac-
tically oriented programme.
In order to obtain a sample of ten subjects reporting SAD,
as a minimum for the statistical analyses, a convenience
sample of 180 subjects from eight classes (year 1-3) was
selected. The size was due to an estimated prevalence rate
of 4-14% of SAD in adolescents [1,2,14,43] and an
expected absent rate of 10-15% on one school day [44].
The response rate at the first assessment was 85% and
79% at the second, resulting in a total of 169 subjects par-
ticipating at any of the assessments. The subjects in the
total sample were in the 1st (n = 62), 2nd (n = 67) and 3rd
(n = 40) year of studies. Mean age was 16.8 years (range
15-18 years). See Table 1 for further demographics of the
total sample.
Reliability sample
At the first assessment (n = 153) 89 boys, (58%) and 64
girls (42%) participated and at the second assessment (n
= 143), 88 boys (61%) and 55 girls (39%). A total of 127
subjects participated at both measurements with the
SPSQ-C and data from these subjects were used for the
analysis of test-retest reliability.
Validity sample
In the present study a sample size of fifty subjects was cho-
sen in order to have enough power for the evaluation of
validity. Thirteen subjects reported SAD at both assess-
ments or at one if only participating at one occasion and
were eligible for the validity study (6/13 subjects had par-
ticipated at both assessments and seven at one assess-
ment). In order to get a sample of fifty subjects, thirty-
eight non-cases were blindly and randomly selected by a
person who was not involved in the project. A total of
fifty-one subjects (26 males and 25 females) were inter-
viewed. Seven subjects declined to participate and were
substituted by the next numbered subject on the list for
randomized selection. Non-responders consisted of one
subject who reported SAD on the SPSQ-C and seven sub-
jects who had not reported SAD. The non-responders were
all male from the second year of their social science stud-
ies.
Instruments
The Social Phobia Screening Questionnaire for Children and 
adolescents (SPSQ-C)
The SPSQ-C is a modified version of the Social Phobia
Screening Questionnaire (SPSQ) for adults [32]. The
SPSQ has shown satisfactory psychometric properties; an
alpha coefficient of .90 concerning the section with fear
ratings and high values of sensitivity and specificity [32].
The diagnostic section of the SPSQ-C is based on 8 poten-
tially phobic situation: "speaking in front of the class",
"raising your hand during a lesson", "being together with
others during breaks", "initiating a conversation with
someone one does not know very well", "looking some-
one in the eyes during a conversation", "making a phone-
call to someone one does not know very well", "going to
a party", and "eating together with others during the
lunch-break". The respondents rate their perceived social
fear in these potentially phobic situations on a three-point
scale corresponding to no fear, some fear, and marked
fear. Five diagnostic questions follow, assessing whether
the individual meets the DSM-IV social phobia criteria A,
B and D for one or more of the phobic situations. Since
the instrument is developed for adolescents up to the age
Table 1: Socio-demographics of the total sample (N = 169).
Age* n (%)
15 2 (1.2)
16 63 (37.3)
17 61 (36.1)
18 42 (24.9)
Gender
Male 100 (59.2)
Female 69 (40.8)
Birth of origin
Swedish 156 (92.3)
Foreign 13 (7.7)
Parents' birth of origin
Swedish, both 150 (88.9)
Foreign, one parent 9 (5.3)
Foreign, both 10 (5.9)
Living arrangement*
With parents 136 (80.5)
With non-family** 31 (18.3)
Alone 1 (0.6)
*data missing in one case
** living with friend, partner or at boarding-schoolChild and Adolescent Psychiatry and Mental Health 2009, 3:36 http://www.capmh.com/content/3/1/36
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of 18, the C-criteria, realizing that the fear is excessive or
unreasonable, does not have to be fulfilled. The E-crite-
rion is assessed with three yes/no questions, i.e. the stu-
dent is asked whether the social fear is of such nature that
it severely interfere with or severely interfered with his/her
activities in school, during leisure-time or when being
with peers. The last question covers the F-criterion of 6-
month duration (yes/no question). Criteria G (the fear is
not due to direct physiological effects of a substance or
medical condition, and not better accounted for by
another mental disorder) and H (if a general medical con-
dition or another mental disorder is present, the social
fear is unrelated to it) are not assessed.
In order to establish a diagnosis of SAD on the SPSQ-C,
i.e. a probable case of SAD, the student had to rate at least
one potentially phobic situation as "marked fear" on the
social fear scale. This particular situation had to be con-
sistently endorsed in the diagnostic questions covering
social phobia criteria A, B and D. The E-criterion had to be
met, i.e. the report of impairment in at least one of the
three life domains assessed. Lastly, the F-criterion, con-
cerning persistence of symptoms for more than six
months, also had to be fulfilled.
The SPSQ-C can be used dimensionally to determine sub-
types of SAD and to measure severity of social anxiety. In
the present paper, only data on a categorical level is pre-
sented. Different cut-off levels have beentested in the
development phase of the SPSQ-C [1] and this was also
done when the adult version of the SPSQ was developed
[32]. The cut-off used is the closest to adhere to the DSM-
IV definition of social phobia.
A paper and pencil format of the SPSQ-C was used. The
instrument took about 5-10 minutes to fill out.
The Structured Clinical Interview for DSM-IV Axis 1 Disorder 
(SCID-1)
To evaluate concurrent validity, the SPSQ-C was com-
pared with the SCID-I [40] used as gold standard. For the
purpose of this study, only the section covering SAD in the
research version of the SCID-I was used. The social phobia
section of the SCID has previously been used in a tele-
phone format with students from the age of 17 [45]. The
interviews were made by a student in the last year of his
master graduation of psychology studies with basic train-
ing in the diagnostic procedures and by a mental health
professional with long experience in using rating scales
and diagnostic interviews in clinical and research con-
texts. The mental health professional conducted 35 of the
51 interviews. The respondents were interviewed by tele-
phone and the interview took 5-20 minutes to conduct.
The interviewers were blind to the subjects' response on
the SPSQ-C.
Statistical analyses
Chi-square or Fisher's exact tests were used for evaluating
group differences with respect to categorical variables.
Test-retest reliability was assessed using Spearman's corre-
lation coefficient. The internal consistency of the scale was
assessed using the Cronbach's coefficient alpha for the
first eight items of the SPSQ-C (data from the first assess-
ment). Specificity (1-α) and sensitivity (1-β), positive and
negative likelihood ratios were calculated as well as posi-
tive predictive value (PPV) and negative predictive value
(NPV). All analyses were performed in SPSS version 15.0
(SPSS, Inc., Chicago, IL, USA).
Results
Descriptives
At the first measurement (n = 153) eleven subjects (7.2%)
met the criteria for SAD according to the SPSQ-C (4.5% of
the males and 10.9% of the females) and 7.7% (4.5% of
the males and 12.7% of the females) at the second meas-
urement (n = 143). There was no significant difference
between the genders in reporting SAD on the SPSC-Q nei-
ther at the first measurement (χ2 = 2.32, df = 1, = ns) or
the second (χ2 = 3.19, df = 1, = ns). No significant differ-
ences were found between cases and non-cases on any of
the demographic variables.
Measures of reliability
The alpha coefficient for the first items on eight phobic sit-
uations in the SPSQ-C was .77. Reliability test-retest anal-
ysis yielded a correlation of r = .60 (P < .01) between the
two assessments. In addition, we also calculated an intra-
class correlation (ICC) and a significant correlation coef-
ficient of .75, was found.
Measures of validity
The overall test accuracy, i.e. the percentage of correct
diagnoses in the validity sample, was 84%. The area under
the curve (AUC) was .79 which was significant in compar-
ison to a random ROC line (P < .015), see Figure 1. ROC-
analysis showed sensitivity to be 71% and specificity 86%.
This means that 71% of the respondents who were
screened positive on the SPSQ-C were diagnosed with
SAD on the SCID-I (5/7), and that 86% (38/44) scored
negative on the SPSQ-C and were not diagnosed with SAD
on the SCID-I. Accordingly, the positive likelihood ratio
(LR+) was 5.07. This means that a self-reported case of
SAD is about 5 times more likely to be a true case than a
non-case. The negative likelihood ratio (LR-) was .34. This
means that a negative screen on the SPSQ-C is marginally
likely to identify a true non-case.
Predictive values represent the probability of an outcome
after the results are known. In the present study, positive
predictive value (PPV), the percentage of positive screens
that are accurate, was 45% (5/11). Negative predictiveChild and Adolescent Psychiatry and Mental Health 2009, 3:36 http://www.capmh.com/content/3/1/36
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value (NPV), i.e. the percentage of respondents screening
with a negative test result who were not diagnosed with
SAD, was 95% (38/40).
Discussion
The aim of the present study was to evaluate the psycho-
metric properties of a screening questionnaire for SAD in
a community sample of Swedish adolescents. Firstly, sat-
isfactory reliability was found. Concerning internal con-
sistency, an alpha coefficient should be at least .60 for a
self-report instrument to be reliable [46]. In the present
study an alpha coefficient of .78 was found, showing that
the eight items on the SPSQ-C are highly internally con-
sistent and that the items appear to measure a common
structure. In measuring test-retest reliability, we found a
positive correlation of temporal stability over a three week
period of r = .60. In measuring reliability, values of .50 to
.70 are considered moderate [47]. Studies of other self-
report measurements of SAD or social anxiety show long-
term and short-term test-retest correlations ranging from
.47 to .86 [26,29,48]. The test-retest reliability and intra-
class correlation of SPSQ-C is thus by and large compara-
ble to those of well-established measures in use for the
assessment of SAD in children and adolescents.
Secondly, concurrent validity was assessed, yielding a spe-
cificity of 86% and a sensitivity of 71%. These values are
comparable to other instruments screening for symptoms
of social anxiety [20]. Sensitivity values of at least 70% are
considered essential [49]. The greater value of specificity,
the more cost-efficient is the instrument and a specificity
value above 80% is considered useful [49]. The AUC was
.79. Values of .70-.80 are considered fair and >.80 as good
[20,50]. In determining the optimal cut-off point, it has
been suggested that the costs of false positives and false
negatives should be considered [51]. In the present study
we did not calculate cut-off scores based on cost-effi-
ciency.
In addition to evaluating sensitivity and specificity, it is of
clinical interest to describe predictive values. The negative
predictive value was 95%, i.e. the probability that SPSQ-C
correctly identifies individuals with no SAD. We found a
positive predictive value of 45%. The predictive values are
influenced by prevalence rates and low prevalence rates
produce higher NPV and lower PPV. In the present study
a prevalence rate of 7.2% was found at the first assessment
and 7.7% at the second assessment.
There are some limitations to be mentioned in relation to
the results from the present study. First, only concurrent
validity was assessed. For clinical purpose, it would be of
value to differentiate SAD from other clinical conditions
but in the present study discriminant validity of the SPSQ-
C was not investigated. Symptoms of anxiety are part of
normal development and screening instruments need to
have the ability to discriminate those with disabling
symptoms from those within normal levels of worry and
anxiety [47]. Thus, the SPSQ-C should be evaluated in
comparisons with other instruments and behavioral
assessment. Detection of social anxiety needs to take place
early in order to prevent the development of further men-
tal illness. Thus, it is of interest to evaluate the SPSQ-C in
a community sample in the first place. It is also of interest
to evaluate the SPSQ-C in clinical groups and to study the
instrument's ability to measure severity and treatment
efficacy [22,52]. Further studies of the SPSQ-C should
include the evaluation of convergent validity by compar-
ing the SPSQ-C to other self-report measures.
Second, the subjects in the present study were high-school
students. Onset of SAD is usually in early- to mid-adoles-
cence but has been diagnosed in children as young as 7-8
years-old [53]. Assessment methods should be develop-
mentally sensitive [21,52,54]. There are difficulties in
developing questionnaires that are suitable for different
ages [55] and little work has been done on early identifi-
cation and assessment of social anxiety in children [54].
In this first report only adolescents were included but psy-
chometric evaluation in younger age groups is needed.
A third limitation is the small sample size. The power of
the statistical analyses would have increased by a larger
number of subjects.
Receiver operation characteristics (ROC) curve for the  SPSQ-C Figure 1
Receiver operation characteristics (ROC) curve for 
the SPSQ-C.
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Lastly, recruitment of participants for the evaluation of
validity was made from two different assessments. This
was done in order to make ecological use of data but it
also results in variability between subjects regarding the
time-span between the measurements with SPSQ-C and
the SCID-I.
As a final comment, better detection of social anxiety dis-
order is not a goal in itself, i.e. screening should be done
only when further assessment, treatment and follow-up
also is offered [56]. Unfortunately, there are frequently
barriers to treatment utilization [57,58] and little is
known on how to increase mental health utilization
among socially phobic individuals [59]. Finding methods
that could make treatment available for socially anxious
children and adolescents remains a challenge.
Conclusion
Screening of SAD in adolescents is critical for prevention
and treatment. Compared to other self-reports question-
naires, the SPSQ-C has the advantage of being a short and
cost-efficient screening instrument, based on the DSM-IV
criteria of social anxiety disorder including measures of
impairment and duration of SAD but also measures on a
dimensional level. The results lend support to that it is a
reliable and valid screening device for non-clinical older
adolescents.
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